90 related articles for article (PubMed ID: 16603190)
1. ZM336372, a Raf-1 activator, inhibits growth of pheochromocytoma cells.
Kappes A; Vaccaro A; Kunnimalaiyaan M; Chen H
J Surg Res; 2006 Jun; 133(1):42-5. PubMed ID: 16603190
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic tyrosine kinase NPM/ALK induces activation of the MEK/ERK signaling pathway independently of c-Raf.
Marzec M; Kasprzycka M; Liu X; Raghunath PN; Wlodarski P; Wasik MA
Oncogene; 2007 Feb; 26(6):813-21. PubMed ID: 16909118
[TBL] [Abstract][Full Text] [Related]
3. Raf-1 activation suppresses neuroendocrine marker and hormone levels in human gastrointestinal carcinoid cells.
Sippel RS; Carpenter JE; Kunnimalaiyaan M; Lagerholm S; Chen H
Am J Physiol Gastrointest Liver Physiol; 2003 Aug; 285(2):G245-54. PubMed ID: 12851216
[TBL] [Abstract][Full Text] [Related]
4. ZM336372, a Raf-1 activator, suppresses growth and neuroendocrine hormone levels in carcinoid tumor cells.
Van Gompel JJ; Kunnimalaiyaan M; Holen K; Chen H
Mol Cancer Ther; 2005 Jun; 4(6):910-7. PubMed ID: 15956248
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor 1 signaling in human gastrointestinal carcinoid tumor cells.
Van Gompel JJ; Chen H
Surgery; 2004 Dec; 136(6):1297-302. PubMed ID: 15657590
[TBL] [Abstract][Full Text] [Related]
6. In-vivo activation of Raf-1 inhibits tumor growth and development in a xenograft model of human medullary thyroid cancer.
Vaccaro A; Chen H; Kunnimalaiyaan M
Anticancer Drugs; 2006 Aug; 17(7):849-53. PubMed ID: 16926634
[TBL] [Abstract][Full Text] [Related]
7. Neuroendocrine tumor cell growth inhibition by ZM336372 through alterations in multiple signaling pathways.
Kunnimalaiyaan M; Ndiaye M; Chen H
Surgery; 2007 Dec; 142(6):959-64; discussion 959-64. PubMed ID: 18063082
[TBL] [Abstract][Full Text] [Related]
8. Activation of the ras/raf-1 signal transduction pathway in carcinoid tumor cells results in morphologic transdifferentiation.
Sippel RS; Chen H
Surgery; 2002 Dec; 132(6):1035-9; discussion 1039. PubMed ID: 12490852
[TBL] [Abstract][Full Text] [Related]
9. Parathyroid hormone inhibits phosphorylation of mitogen-activated protein kinase (MAPK) ERK1/2 through inhibition of c-Raf and activation of MKP-1 in osteoblastic cells.
Lai LP; Mitchell J
Cell Biochem Funct; 2009 Jul; 27(5):269-75. PubMed ID: 19384851
[TBL] [Abstract][Full Text] [Related]
10. ZM336372, a Raf-1 activator, causes suppression of proliferation in a human hepatocellular carcinoma cell line.
Deming D; Geiger P; Chen H; Vaccaro A; Kunnimalaiyaan M; Holen K
J Gastrointest Surg; 2008 May; 12(5):852-7. PubMed ID: 18299943
[TBL] [Abstract][Full Text] [Related]
11. Flagellin and lipopolysaccharide stimulate the MEK-ERK signaling pathway in chicken heterophils through differential activation of the small GTPases, Ras and Rap1.
Kogut MH; Genovese KJ; He H
Mol Immunol; 2007 Mar; 44(7):1729-36. PubMed ID: 17045653
[TBL] [Abstract][Full Text] [Related]
12. Lithium ions: a novel treatment for pheochromocytomas and paragangliomas.
Kappes A; Vaccaro A; Kunnimalaiyaan M; Chen H
Surgery; 2007 Feb; 141(2):161-5; discussion 165. PubMed ID: 17263970
[TBL] [Abstract][Full Text] [Related]
13. Raf-1 kinase activation is uncoupled from downstream MEK/ERK pathway in cells treated with Src tyrosine kinase inhibitor PP2.
Lee M
Biochem Biophys Res Commun; 2006 Nov; 350(2):450-6. PubMed ID: 17010316
[TBL] [Abstract][Full Text] [Related]
14. A chemical biology approach identifies a beta-2 adrenergic receptor agonist that causes human tumor regression by blocking the Raf-1/Mek-1/Erk1/2 pathway.
Carie AE; Sebti SM
Oncogene; 2007 May; 26(26):3777-88. PubMed ID: 17260025
[TBL] [Abstract][Full Text] [Related]
15. [Effects of extracellular signal-regulated kinase/mitogen-activated protein kinase signaling pathway activation on proliferation and cell cycle associated genes in human colon cancer cells].
Wang X; Lu R; Fang JY
Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(14):982-6. PubMed ID: 17650425
[TBL] [Abstract][Full Text] [Related]
16. Growth factor-induced MAPK network topology shapes Erk response determining PC-12 cell fate.
Santos SD; Verveer PJ; Bastiaens PI
Nat Cell Biol; 2007 Mar; 9(3):324-30. PubMed ID: 17310240
[TBL] [Abstract][Full Text] [Related]
17. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
[TBL] [Abstract][Full Text] [Related]
18. Activation of the RAF/mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway mediates apoptosis induced by chelerythrine in osteosarcoma.
Yang R; Piperdi S; Gorlick R
Clin Cancer Res; 2008 Oct; 14(20):6396-404. PubMed ID: 18927278
[TBL] [Abstract][Full Text] [Related]
19. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer.
Roberts PJ; Der CJ
Oncogene; 2007 May; 26(22):3291-310. PubMed ID: 17496923
[TBL] [Abstract][Full Text] [Related]
20. The Raf-1 pathway: a molecular target for treatment of select neuroendocrine tumors?
Kunnimalaiyaan M; Chen H
Anticancer Drugs; 2006 Feb; 17(2):139-42. PubMed ID: 16428931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
